1. Home
  2. TRX vs AVTX Comparison

TRX vs AVTX Comparison

Compare TRX & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • AVTX
  • Stock Information
  • Founded
  • TRX 1990
  • AVTX 2011
  • Country
  • TRX Canada
  • AVTX United States
  • Employees
  • TRX N/A
  • AVTX N/A
  • Industry
  • TRX
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRX
  • AVTX Health Care
  • Exchange
  • TRX Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • TRX 85.7M
  • AVTX 88.4M
  • IPO Year
  • TRX N/A
  • AVTX 2015
  • Fundamental
  • Price
  • TRX $0.32
  • AVTX $8.18
  • Analyst Decision
  • TRX Strong Buy
  • AVTX Strong Buy
  • Analyst Count
  • TRX 2
  • AVTX 4
  • Target Price
  • TRX $1.63
  • AVTX $33.00
  • AVG Volume (30 Days)
  • TRX 428.4K
  • AVTX 64.7K
  • Earning Date
  • TRX 01-14-2025
  • AVTX 03-28-2025
  • Dividend Yield
  • TRX N/A
  • AVTX N/A
  • EPS Growth
  • TRX N/A
  • AVTX N/A
  • EPS
  • TRX 0.01
  • AVTX N/A
  • Revenue
  • TRX $44,282,000.00
  • AVTX $820,000.00
  • Revenue This Year
  • TRX $69.93
  • AVTX N/A
  • Revenue Next Year
  • TRX $21.44
  • AVTX N/A
  • P/E Ratio
  • TRX $63.10
  • AVTX N/A
  • Revenue Growth
  • TRX 16.51
  • AVTX N/A
  • 52 Week Low
  • TRX $0.28
  • AVTX $4.18
  • 52 Week High
  • TRX $0.49
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • TRX 52.07
  • AVTX 52.50
  • Support Level
  • TRX $0.32
  • AVTX $7.82
  • Resistance Level
  • TRX $0.34
  • AVTX $8.50
  • Average True Range (ATR)
  • TRX 0.01
  • AVTX 0.78
  • MACD
  • TRX 0.00
  • AVTX 0.20
  • Stochastic Oscillator
  • TRX 65.50
  • AVTX 73.11

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: